New Legislation Would Cut Off Access To The Courts And Immunize FDA Actions From Timely Judicial Review
The FDA Law Blog
APRIL 30, 2023
Senate Committee on Health, Education, Labor and Pensions (“Senate HELP”) is scheduled to take up legislation that could significantly limit access to the courts and immunize critical FDA decisions from timely judicial review. Subsection 505(q) initially was added by Section 914 of the 2007 FDA Amendments Act (“FDAAA”), Pub.
Let's personalize your content